Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06089070 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring System Feasibility in Youth With T2D

A NA study of Type 2 Diabetes, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06089070 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06089070, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The primary scientific question of this proposal is to investigate whether youth with T2D will wear and interact with a continuous glucose monitor (CGM) system and whether this will influence behavior and management decisions. There will be 30 participants enrolled in the study. 20 in the treatment arm and 10 in the control. The length of study participation will be 6 months for each participant.

Conditions Studied

Interventions

  • DEVICE FreeStyle Libre Continuous Glucose Monitor System

Study Locations (1)

California

  • University of California San Francisco (UCSF) - San Francisco

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-01-03
Est. Completion 2027-12-01
Phase NA

What the Registry Record Tells You About NCT06089070

The ClinicalTrials.gov registry entry for NCT06089070 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which FreeStyle Libre Continuous Glucose Monitor System is the first listed.

NCT06089070 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06089070 about?

NCT06089070 is a clinical study titled "Continuous Glucose Monitoring System Feasibility in Youth With T2D". The primary scientific question of this proposal is to investigate whether youth with T2D will wear and interact with a continuous glucose monitor (CGM) system and whether this will influence behavior and management decisions. There will be 30 participants enrolled in the study. 20 in the treatment ...

What is the current status of trial NCT06089070?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-01-03. Estimated completion is 2027-12-01.

What conditions does trial NCT06089070 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT06089070?

The interventions under investigation include: FreeStyle Libre Continuous Glucose Monitor System (DEVICE).

Who is sponsoring clinical trial NCT06089070?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06089070 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.